newsfilter
← Latest News
GlobeNewswire·

DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program

TORONTO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a generative artificial intelligence healthcare company, is pleased to announce it has been